[Image: Facebook] The Birkin Bag’s status as the most desirable accessory in the world was dealt a prehistoric blow last week when scientists unveiled something a little cooler: the world’s first handbag made from lab-grown ‘T-Rex leather’. The one-of-a-kind luxury handbag, designed by Polish techwear label Enfin Levé, was created through a collaboration between creative agency VML, The Organoid Company and Lab-Grown Leather Ltd. Researchers reconstructed collagen protein sequences from 66-million-year-old Tyrannosaurus rex fossils, used computational modelling to fill genetic gaps, and grew the material in a lab using cell-based technology. The leather was then put through the conventional tanning…
Author: Isla
As China’s largest steel producer navigates global trade tensions and domestic demand shifts, Baoshan Iron & Steel Co offers a unique play for diversified portfolios. Here’s why this stock matters for your investments today, whether you’re in the U.S., Europe, or elsewhere. ISIN: CNE000001969 You’re looking at Baoshan Iron & Steel Co., one of China’s steel giants, and wondering if it’s time to add it to your portfolio. This company powers everything from skyscrapers to cars, but with steel prices volatile and trade policies in flux, timing matters. Let’s break down what drives this stock and whether it fits your…
Valuation Metrics: A Closer Look Sunflag Iron & Steel’s current price-to-earnings (P/E) ratio stands at 19.80, positioning it favourably within its peer group. This P/E is lower than several competitors such as Shyam Metalics (24.11) and Godawari Power (25.67), both rated as very expensive, but higher than Jindal Saw’s very attractive 11.41 and Maharashtra Seamless’s attractive 9.71. The company’s price-to-book value (P/BV) is a compelling 0.51, indicating the stock is trading at roughly half its book value, a classic sign of undervaluation in capital-intensive industries like ferrous metals. Enterprise value to EBITDA (EV/EBITDA) ratio for Sunflag Iron is 10.40, which…
The National Company Law Appellate Tribunal (NCLAT) has rejected an appeal by five banks concerning the distribution of funds in the OCL Iron and Steel insolvency case. The banks, including Indian Bank and ICICI Bank, had challenged the payment to dissenting creditors, the State Bank of India (SBI) and Punjab National Bank.A two-member NCLAT bench ruled that the distribution plan, as approved by the Committee of Creditors (CoC) and backed by the National Company Law Tribunal (NCLT), is lawful. The tribunal affirms that the ‘Monitoring Committee’ formed post-bid could not alter the funds allocation mechanism.This controversy emerged after OCL…
Apr 9, 2026 A study by the Japan Iron and Steel Federation projects global steel scrap collection will reach 873 million tons by 2050. According to the JISF, this figure represents a downward revision of 31 million tons from a previous forecast.Despite this reduction, scrap generation is still expected to show long-term growth, increasing by 36% from 2020 levels. The updated forecast highlights intensifying regional variations in scrap collection.By 2050, developing countries outside of China are now expected to collect 370 million tons of scrap, an upward revision of 16 million tons. In contrast, the forecast for China has been…
EnglishEnglishSelect market data provided by ICE Data Services. Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.Copyright © 2026, American Bankers Association. CUSIP Database provided by FactSet Research Systems Inc. All rights reserved. SEC fillings and other documents provided by Quartr.© 2026 TradingView, Inc. Source link
The cooperation aims to increase local production and facilitate knowledge transfer in the industrial sector. Under the agreement, it is planned to produce seamless and spiral steel pipes in Saudi Arabia—products that were previously imported and are used in critical sectors such as water and gas. Within the scope of the partnership, an integrated industrial ecosystem will be established in the country. This is expected to enhance production capacity and improve efficiency across the sector. The agreement will also strengthen SAAL’s role as a strategic local partner while contributing to the development of the country’s industrial infrastructure and its self-sufficiency…
TORONTO, April 09, 2026 (GLOBE NEWSWIRE) — Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL) (“ Satellos ” or the “ Company ”), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today announced that it will participate in the Bloom Burton & Co. Healthcare Investor Conference taking place April 21-22, 2026, at the Metro Toronto Convention Centre in Toronto, Canada. Satellos Co-founder and CEO Frank Gleeson will provide a presentation on April 21 and along with Liz Williams, Chief Financial Officer, will participate in one-on-one meetings during the conference.2026 Bloom Burton & Co. Healthcare Investor ConferenceFormat: Presentation and webcastPresenter: Frank Gleeson, President…
Interoperability remains one of the most critical challenges in modern healthcare IT. Despite significant digitization across the industry, many organizations still operate with fragmented systems that cannot communicate effectively. Electronic health records, laboratory systems, imaging platforms, billing tools, and external applications often exist in isolation, creating data silos that limit efficiency and compromise patient care.The growing need for real-time, accurate, and secure data exchange has made interoperability a strategic priority rather than a technical afterthought. A modern solution to this challenge is the adoption of HL7 FHIR (Fast Healthcare Interoperability Resources), a framework designed to enable seamless communication between disparate…
Andreas EdsfeldtImage source: Lund University; photo: Petra Olsson The team created genetic risk scores and found that the scores for one subgroup could predict coronary artery disease, even before onset of diabetes. Diabetes increases the risk of developing coronary artery disease, a common form of cardiovascular disease, often caused by atherosclerosis. Andreas Edsfeldt, who works as cardiologist, meets many patients with coronary artery disease who also turn out to have type 2 diabetes. Myocardial infarction is one example of coronary artery disease. “Type 2 diabetes is a silent disease which is often detected when the patient is seeking care for complications, such…